Sharechat Logo

Rua announces closing date for Director Nominations 2022

Tuesday 23rd August 2022

Text too small?

Rua Bioscience Limited (NZX: RUA ) advises the closing date for Director nominations is 5:00pm NZST on Tuesday 6 September 2022.

Nominations may only be made by a shareholder entitled to attend and vote at the meeting, and be accompanied by the consent in writing of the person nominated.

Any nominations should be emailed to:

Hamish.white@ruabio.com

Or addressed to:

Director Nominations

Attn: Hamish White

CFO and Company Secretary

Rua Bioscience

PO Box 1387

Gisborne, 4040

Rua takes this opportunity to remind Shareholders that its 2022 Annual Meeting will be held at 10:00am (New Zealand time) on 12 October 2022. The meeting will be a hybrid meeting hosted at Waikanae Surf Club, Grey St, Gisborne and supported by a virtual meeting platform.

Further details for participation and voting online will be included in the formal Notice of Annual Shareholders’ Meeting which will be released prior to the meeting.

ENDS

2022 Director Nominations and Annual Meeting Announcement



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Chorus considers Capital Notes offer
May 5th Morning Report
KPG - Kiwi Property announces GM Corporate Services
Mainfreight Limited - Trading Conditions Update 2 May 2025
SIML - Change to Executive Team
BAI - Divestment of education group
May 2nd Morning Report
MMH - Marsden Maritime Holdings (MMH) releases Scheme Booklet
CVT - Comvita announces change to Board of Directors
TRU - Published Saudi Arabia Study Confirms TruScreen's Results